CA Patent

CA3151789A1 — Compounds and methods useful for modulating gene splicing

Assigned to Arnay Sciences LLC · Expires 2021-03-25 · 5y expired

What this patent protects

The present invention is directed to compounds, compositions, and methods useful for modulating gene splicing. In some embodiments, modulating gene splicing increases expression of a target protein or a target functional RNA.

USPTO Abstract

The present invention is directed to compounds, compositions, and methods useful for modulating gene splicing. In some embodiments, modulating gene splicing increases expression of a target protein or a target functional RNA.

Drugs covered by this patent

Patent Metadata

Patent number
CA3151789A1
Jurisdiction
CA
Classification
—
Expires
2021-03-25
Drug substance claim
No
Drug product claim
No
Assignee
Arnay Sciences LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.